JP2002526123A - 核酸多形現象の検出 - Google Patents
核酸多形現象の検出Info
- Publication number
- JP2002526123A JP2002526123A JP2000574725A JP2000574725A JP2002526123A JP 2002526123 A JP2002526123 A JP 2002526123A JP 2000574725 A JP2000574725 A JP 2000574725A JP 2000574725 A JP2000574725 A JP 2000574725A JP 2002526123 A JP2002526123 A JP 2002526123A
- Authority
- JP
- Japan
- Prior art keywords
- probe
- dna
- complex
- single strand
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title description 18
- 150000007523 nucleic acids Chemical class 0.000 title description 4
- 102000039446 nucleic acids Human genes 0.000 title description 2
- 108020004707 nucleic acids Proteins 0.000 title description 2
- 239000000523 sample Substances 0.000 claims abstract description 284
- 108020004414 DNA Proteins 0.000 claims abstract description 206
- 108700028369 Alleles Proteins 0.000 claims abstract description 129
- 238000000034 method Methods 0.000 claims abstract description 70
- 230000035772 mutation Effects 0.000 claims abstract description 64
- 238000006243 chemical reaction Methods 0.000 claims abstract description 48
- 238000009396 hybridization Methods 0.000 claims abstract description 42
- 238000004925 denaturation Methods 0.000 claims abstract description 29
- 230000036425 denaturation Effects 0.000 claims abstract description 29
- 239000003550 marker Substances 0.000 claims abstract description 23
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 22
- 238000010494 dissociation reaction Methods 0.000 claims abstract description 18
- 230000005593 dissociations Effects 0.000 claims abstract description 18
- 230000008859 change Effects 0.000 claims abstract description 15
- 230000003993 interaction Effects 0.000 claims abstract description 12
- 239000000872 buffer Substances 0.000 claims description 58
- 102000053602 DNA Human genes 0.000 claims description 56
- 108091034117 Oligonucleotide Proteins 0.000 claims description 34
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 22
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical group CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 claims description 19
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical group OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 17
- 108010090804 Streptavidin Proteins 0.000 claims description 17
- 238000000137 annealing Methods 0.000 claims description 15
- 230000009946 DNA mutation Effects 0.000 claims description 11
- 229960002685 biotin Drugs 0.000 claims description 11
- 235000020958 biotin Nutrition 0.000 claims description 11
- 239000011616 biotin Substances 0.000 claims description 11
- 238000005259 measurement Methods 0.000 claims description 8
- 230000007613 environmental effect Effects 0.000 claims description 6
- 230000002596 correlated effect Effects 0.000 claims description 4
- 238000009830 intercalation Methods 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 37
- 239000002773 nucleotide Substances 0.000 abstract description 23
- 125000003729 nucleotide group Chemical group 0.000 abstract description 23
- 238000012544 monitoring process Methods 0.000 abstract description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 100
- 238000003556 assay Methods 0.000 description 79
- 239000000047 product Substances 0.000 description 64
- 239000000975 dye Substances 0.000 description 62
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 44
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 230000027455 binding Effects 0.000 description 30
- 239000000243 solution Substances 0.000 description 30
- 238000012360 testing method Methods 0.000 description 25
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 23
- 239000002751 oligonucleotide probe Substances 0.000 description 23
- 108020004682 Single-Stranded DNA Proteins 0.000 description 22
- 239000011780 sodium chloride Substances 0.000 description 22
- 230000007423 decrease Effects 0.000 description 20
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- 238000010438 heat treatment Methods 0.000 description 16
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 239000007787 solid Substances 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 10
- 101100079754 Homo sapiens NDUFB4 gene Proteins 0.000 description 8
- 101150096081 NDUFB4 gene Proteins 0.000 description 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- 239000000654 additive Substances 0.000 description 8
- 229910052786 argon Inorganic materials 0.000 description 8
- 238000001506 fluorescence spectroscopy Methods 0.000 description 8
- 239000010931 gold Substances 0.000 description 8
- 229910052737 gold Inorganic materials 0.000 description 8
- 238000006386 neutralization reaction Methods 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000009918 complex formation Effects 0.000 description 6
- 238000012937 correction Methods 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000001917 fluorescence detection Methods 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000002563 ionic surfactant Substances 0.000 description 6
- 102000054765 polymorphisms of proteins Human genes 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000000539 dimer Substances 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000001046 green dye Substances 0.000 description 4
- 238000007403 mPCR Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000002028 premature Effects 0.000 description 4
- 241000282412 Homo Species 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- 239000012807 PCR reagent Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
- 239000007994 TES buffer Substances 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-O acridine;hydron Chemical compound C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-O 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000002820 assay format Methods 0.000 description 2
- 238000007846 asymmetric PCR Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000000368 destabilizing effect Effects 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 238000003505 heat denaturation Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000009149 molecular binding Effects 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101001128608 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 Proteins 0.000 description 1
- 102100032205 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9821989.2A GB9821989D0 (en) | 1998-10-08 | 1998-10-08 | Detection of nucleic acid polymorphism |
| GB9821989.2 | 1998-10-08 | ||
| PCT/GB1999/003329 WO2000020633A1 (en) | 1998-10-08 | 1999-10-07 | Detection of nucleic acid polymorphism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2002526123A true JP2002526123A (ja) | 2002-08-20 |
Family
ID=10840243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000574725A Pending JP2002526123A (ja) | 1998-10-08 | 1999-10-07 | 核酸多形現象の検出 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7179589B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1117832B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002526123A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE427999T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU744929B2 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69940698D1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB9821989D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000020633A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2009130797A1 (ja) * | 2008-04-22 | 2011-08-11 | 東洋鋼鈑株式会社 | Ａｂｏ式血液型を判定するためのプローブセット |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6900300B1 (en) | 2000-09-19 | 2005-05-31 | Ingeneus Corporation | Quadruplex DNA and duplex probe systems |
| US6858390B2 (en) | 1998-12-31 | 2005-02-22 | Ingeneus Corporation | Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| US6656692B2 (en) | 1999-12-21 | 2003-12-02 | Ingeneus Corporation | Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| US6403313B1 (en) * | 1999-12-21 | 2002-06-11 | Ingeneus Corporation | Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators |
| US6420115B1 (en) | 1999-12-21 | 2002-07-16 | Ingeneus Corporation | Cation mediated triplex hybridization assay |
| US7309569B2 (en) | 1999-12-21 | 2007-12-18 | Ingeneus, Inc. | Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| US6927027B2 (en) | 1999-12-21 | 2005-08-09 | Ingeneus Corporation | Nucleic acid multiplex formation |
| US6911536B1 (en) | 1999-12-21 | 2005-06-28 | Ingeneus Corporation | Triplex and quadruplex catalytic hybridization |
| US6924108B2 (en) | 1999-12-21 | 2005-08-02 | Ingeneus Corporation | Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues |
| US7052844B2 (en) | 1999-12-21 | 2006-05-30 | Ingeneus, Inc. | Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism |
| US6613524B1 (en) | 2000-01-24 | 2003-09-02 | Ingeneus Corporation | Amperometric affinity assay and electrically stimulated complexes of nucleic acids |
| US7220541B2 (en) | 2000-01-24 | 2007-05-22 | Ingeneus, Inc. | Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions |
| US6982147B2 (en) | 2000-01-24 | 2006-01-03 | Ingeneus Corporation | Apparatus for assaying biopolymer binding by means of multiple measurements under varied conditions |
| AU2001234883A1 (en) | 2000-02-10 | 2001-08-20 | The Penn State Research Foundation | Method of analyzing single nucleotide polymorphisms using melting curve and restriction endonuclease digestion |
| US20020182622A1 (en) * | 2001-02-01 | 2002-12-05 | Yusuke Nakamura | Method for SNP (single nucleotide polymorphism) typing |
| EP1558762B1 (en) | 2002-10-23 | 2013-09-11 | University of Utah Research Foundation | Amplicon melting analysis with saturation dyes |
| US7101671B2 (en) * | 2002-10-24 | 2006-09-05 | Ben Gao | Method and equipment to monitor nucleic acid hybridization on a DNA chip using four-dimensional parameters |
| WO2004061130A1 (ja) * | 2002-12-27 | 2004-07-22 | Toyo Boseki Kabushiki Kaisha | 塩基多型の同定方法 |
| US20050064452A1 (en) * | 2003-04-25 | 2005-03-24 | Schmid Matthew J. | System and method for the detection of analytes |
| US9317922B2 (en) | 2003-05-16 | 2016-04-19 | Board Of Regents The University Of Texas System | Image and part recognition technology |
| US20120122103A1 (en) | 2003-09-11 | 2012-05-17 | Rangarajan Sampath | Compositions for use in identification of bacteria |
| US9657347B2 (en) | 2004-04-20 | 2017-05-23 | University of Utah Research Foundation and BioFire Defense, LLC | Nucleic acid melting analysis with saturation dyes |
| JP3916086B2 (ja) * | 2004-06-29 | 2007-05-16 | ソニー株式会社 | ハイブリダイゼーションなどの相互作用を検出する方法及び検出部、該検出部を備えるバイオアッセイ用基板、ハイブリダイゼーションなどの相互作用を検出する装置、並びに試薬キット |
| WO2006127609A2 (en) | 2005-05-23 | 2006-11-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Polymorphism in the macrophage migration inhibitory factor (mif) gene as marker for prostate cancer |
| US20070072193A1 (en) * | 2005-09-27 | 2007-03-29 | Shah Manish M | Ligand arrays having controlled feature size, and methods of making and using the same |
| US20070154892A1 (en) * | 2005-12-30 | 2007-07-05 | Simon Wain-Hobson | Differential amplification of mutant nucleic acids by PCR in a mixure of nucleic acids |
| US8057989B2 (en) | 2006-02-10 | 2011-11-15 | The University Of Hong Kong | Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes |
| US8309304B2 (en) | 2006-02-10 | 2012-11-13 | The University Of Hong Kong | Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes |
| US7555933B2 (en) | 2006-08-01 | 2009-07-07 | Thermo Fisher Scientific Inc. | Method and software for detecting vacuum concentrator ends-of-runs |
| WO2009151982A1 (en) * | 2008-05-30 | 2009-12-17 | Ibis Biosciences, Inc. | Compositions for use in identification of francisella |
| US8219324B2 (en) * | 2008-09-12 | 2012-07-10 | Roche Molecular Systems, Inc. | Real-time PCR elbow calling by equation-less algorithm |
| US20100129796A1 (en) * | 2008-11-24 | 2010-05-27 | Micah Halpern | Dye probe fluorescence resonance energy transfer genotyping |
| WO2010135917A1 (zh) | 2009-05-26 | 2010-12-02 | 厦门大学 | 一种检测核酸序列变异的方法 |
| US10176293B2 (en) | 2012-10-02 | 2019-01-08 | Roche Molecular Systems, Inc. | Universal method to determine real-time PCR cycle threshold values |
| CN106908655B (zh) * | 2017-03-06 | 2019-06-14 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | 光电信号峰值检测方法与系统 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4824776A (en) * | 1985-07-25 | 1989-04-25 | Molecular Biosystems, Inc. | Method for increasing the sensitivity of nucleic acid hybridization assays |
| DE69125441T2 (de) * | 1990-09-28 | 1997-11-06 | Toshiba Kawasaki Kk | Verfahren zum Gennachweis |
| US6048690A (en) * | 1991-11-07 | 2000-04-11 | Nanogen, Inc. | Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
| WO1993010266A1 (en) * | 1991-11-22 | 1993-05-27 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Device and method for detection of compounds which intercalate with nucleic acids |
| EP0730662A4 (en) * | 1993-09-10 | 1999-11-24 | Genevue Inc | OPTICAL DETECTION OF THE POSITION OF OLIGONUCLEOTIDES ON LARGE DNA MOLECULES |
| US5827653A (en) * | 1993-09-23 | 1998-10-27 | Zeneca Limited | Nucleic acid detection with energy transfer |
| CA2591550C (en) * | 1996-06-04 | 2009-04-28 | University Of Utah Research Foundation | Monitoring hybridization during pcr |
| AU6534898A (en) * | 1997-02-14 | 1998-09-08 | E.I. Du Pont De Nemours And Company | Detection of double-stranded dna in a homogeneous solution |
| US6406845B1 (en) * | 1997-05-05 | 2002-06-18 | Trustees Of Tuft College | Fiber optic biosensor for selectively detecting oligonucleotide species in a mixed fluid sample |
| GB9725197D0 (en) * | 1997-11-29 | 1998-01-28 | Secr Defence | Detection system |
| EP1352230A2 (en) * | 2000-12-29 | 2003-10-15 | Chromagen, Inc. | Scanning spectrophotometer for high throughput fluorescence detection |
-
1998
- 1998-10-08 GB GBGB9821989.2A patent/GB9821989D0/en not_active Ceased
-
1999
- 1999-10-07 DE DE69940698T patent/DE69940698D1/de not_active Expired - Lifetime
- 1999-10-07 AT AT99949176T patent/ATE427999T1/de not_active IP Right Cessation
- 1999-10-07 WO PCT/GB1999/003329 patent/WO2000020633A1/en not_active Ceased
- 1999-10-07 EP EP99949176A patent/EP1117832B1/en not_active Expired - Lifetime
- 1999-10-07 JP JP2000574725A patent/JP2002526123A/ja active Pending
- 1999-10-07 AU AU62160/99A patent/AU744929B2/en not_active Ceased
-
2001
- 2001-01-05 US US09/755,747 patent/US7179589B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2009130797A1 (ja) * | 2008-04-22 | 2011-08-11 | 東洋鋼鈑株式会社 | Ａｂｏ式血液型を判定するためのプローブセット |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1117832B1 (en) | 2009-04-08 |
| WO2000020633A1 (en) | 2000-04-13 |
| GB9821989D0 (en) | 1998-12-02 |
| EP1117832A1 (en) | 2001-07-25 |
| US7179589B2 (en) | 2007-02-20 |
| ATE427999T1 (de) | 2009-04-15 |
| AU744929B2 (en) | 2002-03-07 |
| AU6216099A (en) | 2000-04-26 |
| DE69940698D1 (cg-RX-API-DMAC7.html) | 2009-05-20 |
| US20010046670A1 (en) | 2001-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002526123A (ja) | 核酸多形現象の検出 | |
| JP5112592B2 (ja) | ハイブリダイゼーション・ビーコン、並びに迅速に配列を検出および判別する方法 | |
| EP0847449B1 (en) | Method for identification of mutations using ligation of multiple oligonucleotide probes | |
| JP4499987B2 (ja) | 非−標準塩基を使用する固体支持体アッセイ系及び方法 | |
| US6506568B2 (en) | Method of analyzing single nucleotide polymorphisms using melting curve and restriction endonuclease digestion | |
| WO1992016657A1 (en) | Method of identifying a nucleotide present at a defined position in a nucleic acid | |
| WO2002018659A2 (en) | Method for determining alleles | |
| EP1131468A2 (en) | Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids | |
| AU6676898A (en) | Nucleic acid analysis methods | |
| JP4228041B2 (ja) | 塩基多型の検出方法 | |
| US6593092B2 (en) | Beta 2 adrenergic polymorphism detection | |
| US20060008826A1 (en) | Method for determining alleles | |
| KR20120124029A (ko) | 다형 검출용 프로브, 다형 검출 방법, 약효 판정 방법 및 다형 검출용 시약 키트 | |
| EP1683872A1 (en) | Method of increasing discrimination for a single base mismatch using hurdle DNA's and artificially mismatched probes | |
| CN1434873B (zh) | 选择性分离核酸的方法 | |
| US20070269803A1 (en) | Fluorogenic Nucleic Acid Probes Including Lna for Methods to Detect and/or Quantify Nucleic Acid Analytes | |
| JP4310675B2 (ja) | 塩基多型の同定方法 | |
| JP2004141159A (ja) | 核酸沈澱剤を利用した核酸増幅産物のハイブリダイゼーションアッセイ | |
| CA2426346A1 (en) | Genotyping using partially-complementary probes | |
| JP2005287499A (ja) | 塩基多型の同定方法 | |
| JPWO1998002574A1 (ja) | 核酸の検査方法、並びに検査キット | |
| WO2004061130A1 (ja) | 塩基多型の同定方法 |